Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis

One of the commonest causes of end-stage renal disease is diabetic kidney disease (DKD). Renal fibrosis, characterized by the accumulation of extracellular matrix (ECM) proteins in glomerular basement membranes and the tubulointerstitium, is the final manifestation of DKD. The TGF-β pathway triggers...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Sun, Yangwei Wang, Wenpeng Cui, Yan Lou, Guangdong Sun, Dongmei Zhang, Lining Miao
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/7242384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554544830087168
author Jing Sun
Yangwei Wang
Wenpeng Cui
Yan Lou
Guangdong Sun
Dongmei Zhang
Lining Miao
author_facet Jing Sun
Yangwei Wang
Wenpeng Cui
Yan Lou
Guangdong Sun
Dongmei Zhang
Lining Miao
author_sort Jing Sun
collection DOAJ
description One of the commonest causes of end-stage renal disease is diabetic kidney disease (DKD). Renal fibrosis, characterized by the accumulation of extracellular matrix (ECM) proteins in glomerular basement membranes and the tubulointerstitium, is the final manifestation of DKD. The TGF-β pathway triggers epithelial-to-mesenchymal transition (EMT), which plays a key role in the accumulation of ECM proteins in DKD. DCCT/EDIC studies have shown that DKD often persists and progresses despite glycemic control in diabetes once DKD sets in due to prior exposure to hyperglycemia called “metabolic memory.” These imply that epigenetic factors modulate kidney gene expression. There is evidence to suggest that in diabetes and hyperglycemia, epigenetic histone modifications have a significant effect in modulating renal fibrotic and ECM gene expression induced by TGF-β1, as well as its downstream profibrotic genes. Histone modifications are also implicated in renal fibrosis through its ability to regulate the EMT process triggered by TGF-β signaling. In view of this, efforts are being made to develop HAT, HDAC, and HMT inhibitors to delay, stop, or even reverse DKD. In this review, we outline the latest advances that are being made to regulate histone modifications involved in DKD.
format Article
id doaj-art-1073091b18bd47c19a3ffcb238b7a262
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-1073091b18bd47c19a3ffcb238b7a2622025-02-03T05:51:05ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/72423847242384Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal FibrosisJing Sun0Yangwei Wang1Wenpeng Cui2Yan Lou3Guangdong Sun4Dongmei Zhang5Lining Miao6Department of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaOne of the commonest causes of end-stage renal disease is diabetic kidney disease (DKD). Renal fibrosis, characterized by the accumulation of extracellular matrix (ECM) proteins in glomerular basement membranes and the tubulointerstitium, is the final manifestation of DKD. The TGF-β pathway triggers epithelial-to-mesenchymal transition (EMT), which plays a key role in the accumulation of ECM proteins in DKD. DCCT/EDIC studies have shown that DKD often persists and progresses despite glycemic control in diabetes once DKD sets in due to prior exposure to hyperglycemia called “metabolic memory.” These imply that epigenetic factors modulate kidney gene expression. There is evidence to suggest that in diabetes and hyperglycemia, epigenetic histone modifications have a significant effect in modulating renal fibrotic and ECM gene expression induced by TGF-β1, as well as its downstream profibrotic genes. Histone modifications are also implicated in renal fibrosis through its ability to regulate the EMT process triggered by TGF-β signaling. In view of this, efforts are being made to develop HAT, HDAC, and HMT inhibitors to delay, stop, or even reverse DKD. In this review, we outline the latest advances that are being made to regulate histone modifications involved in DKD.http://dx.doi.org/10.1155/2017/7242384
spellingShingle Jing Sun
Yangwei Wang
Wenpeng Cui
Yan Lou
Guangdong Sun
Dongmei Zhang
Lining Miao
Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
Journal of Diabetes Research
title Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
title_full Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
title_fullStr Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
title_full_unstemmed Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
title_short Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
title_sort role of epigenetic histone modifications in diabetic kidney disease involving renal fibrosis
url http://dx.doi.org/10.1155/2017/7242384
work_keys_str_mv AT jingsun roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT yangweiwang roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT wenpengcui roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT yanlou roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT guangdongsun roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT dongmeizhang roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis
AT liningmiao roleofepigenetichistonemodificationsindiabetickidneydiseaseinvolvingrenalfibrosis